Literature DB >> 1745082

Willingness-to-pay as a measure of benefits. Relevant questions in the context of public decisionmaking about health care programs.

A Gafni1.   

Abstract

Keywords:  Analytical Approach; Empirical Approach; Health Care and Public Health; National Health Service

Mesh：

Year:  1991        PMID： 1745082

Source DB:  PubMed          Journal:  Med Care        ISSN： 0025-7079            Impact factor:   2.983


× No keyword cloud information.
  39 in total

Review 1.  Willingness to pay and the valuation of programmes for the prevention and control of influenza.

Authors:  S Birch; A Gafni; B O'Brien
Journal:  Pharmacoeconomics       Date:  1999       Impact factor: 4.981

2.  Willingness to pay. What's in a name?

Authors:  A Gafni
Journal:  Pharmacoeconomics       Date:  1998-11       Impact factor: 4.981

3.  [Focal hyperhidrosis.Quality of life, socioeconomic importance and use of internal medicinal therapy].

Authors:  B Rzany; C Müller; M Hund
Journal:  Hautarzt       Date:  2012-06       Impact factor: 0.751

4.  Preference based outcome measures for economic evaluation of drug interventions: quality adjusted life years (QALYs) versus healthy years equivalents (HYEs).

Authors:  A Mehrez; A Gafni
Journal:  Pharmacoeconomics       Date:  1992-05       Impact factor: 4.981

5.  Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for Pharmacoeconomics.

Authors:  G W Torrance; D Blaker; A Detsky; W Kennedy; F Schubert; D Menon; P Tugwell; R Konchak; E Hubbard; T Firestone
Journal:  Pharmacoeconomics       Date:  1996-06       Impact factor: 4.981

6.  Assessing community values in health care: is the 'willingness to pay' method feasible?

Authors:  C Donaldson; S Farrar; T Mapp; A Walker; S Macphee
Journal:  Health Care Anal       Date:  1997-03

7.  Assessing the economic value of a new antidepressant. A willingness-to-pay approach.

Authors:  B J O'Brien; S Novosel; G Torrance; D Streiner
Journal:  Pharmacoeconomics       Date:  1995-07       Impact factor: 4.981

Review 8.  Willingness to pay for a QALY: theoretical and methodological issues.

Authors:  Dorte Gyrd-Hansen
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

9.  Photodynamic therapy for Barrett's esophagus with high-grade dysplasia: a cost-effectiveness analysis.

Authors:  Dan Comay; Gord Blackhouse; Ron Goeree; David Armstrong; John K Marshall
Journal:  Can J Gastroenterol       Date:  2007-04       Impact factor: 3.522

10.  The cost of laparoscopic myotomy versus pneumatic dilatation for esophageal achalasia.

Authors:  Paul J Karanicolas; Shona E Smith; Richard I Inculet; Richard A Malthaner; Richard P Reynolds; Ron Goeree; Amiram Gafni
Journal:  Surg Endosc       Date:  2007-05-04       Impact factor: 4.584
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.